Results 91 to 100 of about 118,570 (219)

CDK Literature #3

open access: yes, 2008
Third in a series summarizing literature citing one of the two CDK articles. See also #1 and #2 .
openaire   +1 more source

Expression characteristics of dual‐specificity phosphatase 2 and hypoxia‐inducible factor‐1α in acute kidney injury and preliminary study of the effect of dual‐specificity phosphatase 2 on HK‐2 cells

open access: yesExperimental Physiology, EarlyView.
ABSTRACT Acute kidney injury (AKI) is a global health problem with significant long‐term harm if the prognosis is poor. Dual‐specificity phosphatase 2 (DUSP2) is involved in key regulatory pathways in several disease processes, but its function in renal pathophysiology is unclear.
Xueqian Chu   +8 more
wiley   +1 more source

Spatial and temporal scales in plant phenotyping for crop water stress assessment: A review

open access: yesThe Plant Phenome Journal, Volume 9, Issue 1, December 2026.
Abstract Water stress is a major limiting factor for crop productivity worldwide, and its impacts are intensifying due to climate variability and increasing water scarcity. This review focuses on the spatial and temporal scales in plant phenotyping as a critical approach to improving crop water‐stress assessment and supporting precision water ...
Daniel Kingsley Cudjoe   +3 more
wiley   +1 more source

CDK Literature #4

open access: yes, 2008
Fourth in the CDK Literature series. Really, a follow up on #3 which I wanted to get out, even though not really finished yet. But, after 3 comes 4, not 3b. Maybe 3.1, but that suggests at least 3.2-3.9 too, let alone full R (that was supposed to the space of all reals…) I'll stick to positive non-zero integers. #1 and #2 are still available too.
openaire   +1 more source

Trends in Maternal Mortality in Bhutan: A National Review, 1985 to 2024

open access: yesReproductive, Female and Child Health, Volume 5, Issue 2, June 2026.
ABSTRACT Background Maternal mortality remains a major global public health concern, with the highest burden in low‐ and middle‐income countries. Despite global progress, preventable causes such as hemorrhage and hypertensive disorders continue to contribute significantly to maternal deaths.
Yeshey Dorjey   +3 more
wiley   +1 more source

Saikosaponin A Inhibits Migration/Invasion and Triggers Cell‐Cycle Arrest and Autophagy‐Induced Cell Death in HCT116 Cells and In Vivo

open access: yesFood Frontiers, Volume 7, Issue 3, May 2026.
Saikosaponin A from Radix Bupleuri inhibited colorectal cancer HCT116 cells with low toxicity. SSA induced S/G2‐M cell cycle arrest and triggered autophagy via mTOR inhibition. SSA suppressed metastasis by blocking PI3K/AKT signaling pathway. SSA significantly reduced tumor growth without apparent toxicity.
Xiu‐Xiu Zhang   +7 more
wiley   +1 more source

Updating Ruby CDK

open access: yes, 2009
It’s been over two years since Ruby CDK was first announced. For the unfamiliar, Ruby CDK offers a convenient way to use the Chemistry Development Kit from the MRI Ruby implementation. Over the least several months, I’ve received quite a few emails about Ruby CDK.
openaire   +1 more source

Garcinone C Suppresses Cancer Stem Cells and Induces Apoptosis in Triple‐Negative Breast Cancer Through Canonical Wnt Signaling

open access: yesFood Frontiers, Volume 7, Issue 3, May 2026.
Garcinone C (Gar. C), a xanthone derived from mangosteen (Garcinia mangostana), suppresses triple‐negative breast cancer growth and stemness by inducing mitochondrial‐mediated apoptosis and inhibiting the Wnt/β‐catenin pathway, highlighting its potential as a natural compound for the prevention and treatment TNBC.
Danhong Zheng   +4 more
wiley   +1 more source

Predictive Role of Serum Inflammatory Markers in Metastatic Luminal A/B Breast Cancers Receiving CDK‐4/6 Inhibitors Therapy [PDF]

open access: yesImmun Inflamm Dis
ABSTRACT Background We conducted this study to evaluate the impact of serum inflammatory markers and histopathological features on prognosis in metastatic hormone receptor positive breast cancer patients treated with first line CDK4/6i (cyclin‐dependent kinase inhibitors).
Bulut N, Kapagan T, Ozmen A, Erdem G.
europepmc   +2 more sources

Home - About - Disclaimer - Privacy